Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8927514 Recombinant adeno-associated vectors for targeted treatment

Patent 8927514 was granted and assigned to City of Hope on January, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
City of Hope
City of Hope
0
Date Filed
November 2, 2012
0
Date of Patent
January 6, 2015
0
Patent Applicant
City of Hope
City of Hope
0
Patent Application Number
13668120
0
Patent Citations Received
‌
US Patent 12123002 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 12083188 Engineered DNA binding proteins
0
‌
US Patent 12084659 Modulatory polynucleotides
0
‌
US Patent 12091435 Antibody-evading virus vectors
0
‌
US Patent 12104163 Adeno-associated virus vectors for treatment of Rett syndrome
0
‌
US Patent 12116384 Virus vectors for targeting ophthalmic tissues
0
‌
US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)
0
‌
US Patent 11713450 Scalable purification method for AAV1
0
‌
US Patent 11752181 Compositions and methods of treating Huntington's disease
‌
US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease
•••
Patent Inventor Names
Laura Smith
0
Saswati Chatterjee
0
Kamehameha Wong
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8927514
0
Patent Primary Examiner
‌
Marcia S Noble
0

Find more entities like US Patent 8927514 Recombinant adeno-associated vectors for targeted treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.